140 related articles for article (PubMed ID: 12571159)
1. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women.
Worda C; Sator MO; Schneeberger C; Jantschev T; Ferlitsch K; Huber JC
Hum Reprod; 2003 Feb; 18(2):262-6. PubMed ID: 12571159
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.
Wang Q; Wang YP; Li JY; Yuan P; Yang F; Li H
Chin J Cancer; 2010 Jul; 29(7):683-8. PubMed ID: 20591221
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
[TBL] [Abstract][Full Text] [Related]
4. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
5. The COMT val158met polymorphism is associated with peak BMD in men.
Lorentzon M; Eriksson AL; Mellström D; Ohlsson C
J Bone Miner Res; 2004 Dec; 19(12):2005-11. PubMed ID: 15537444
[TBL] [Abstract][Full Text] [Related]
6. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
[TBL] [Abstract][Full Text] [Related]
7. The COMT val158met polymorphism is associated with early pubertal development, height and cortical bone mass in girls.
Eriksson AL; Suuriniemi M; Mahonen A; Cheng S; Ohlsson C
Pediatr Res; 2005 Jul; 58(1):71-7. PubMed ID: 15985686
[TBL] [Abstract][Full Text] [Related]
8. The catechol-O-methyltransferase Met158 low-activity allele and association with nonvertebral fracture risk in elderly men.
Stolk L; van Meurs JB; Jhamai M; Arp PP; van Leeuwen JP; Hofman A; de Jong FH; Pols HA; Uitterlinden AG
J Clin Endocrinol Metab; 2007 Aug; 92(8):3206-12. PubMed ID: 17504906
[TBL] [Abstract][Full Text] [Related]
9. Association between physical activity and BMD in young men is modulated by catechol-O-methyltransferase (COMT) genotype: the GOOD study.
Lorentzon M; Eriksson AL; Nilsson S; Mellström D; Ohlsson C
J Bone Miner Res; 2007 Aug; 22(8):1165-72. PubMed ID: 17451372
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-methyltransferase and breast cancer risk.
Millikan RC; Pittman GS; Tse CK; Duell E; Newman B; Savitz D; Moorman PG; Boissy RJ; Bell DA
Carcinogenesis; 1998 Nov; 19(11):1943-7. PubMed ID: 9855007
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
12. Influence of catechol-O-methyltransferase Val158Met polymorphism on startle response in the presence of high estradiol levels.
Comasco E; Hellgren C; Sundström-Poromaa I
Eur Neuropsychopharmacol; 2013 Jul; 23(7):629-35. PubMed ID: 22831878
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.
Yim DS; Parkb SK; Yoo KY; Yoon KS; Chung HH; Kang HL; Ahn SH; Noh DY; Choe KJ; Jang IJ; Shin SG; Strickland PT; Hirvonen A; Kang D
Pharmacogenetics; 2001 Jun; 11(4):279-86. PubMed ID: 11434504
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
Al-Hendy A; Salama SA
J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
[TBL] [Abstract][Full Text] [Related]
15. Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.
Tofteng CL; Abrahamsen B; Jensen JE; Petersen S; Teilmann J; Kindmark A; Vestergaard P; Gram J; Langdahl BL; Mosekilde L
Calcif Tissue Int; 2004 Aug; 75(2):123-32. PubMed ID: 15129369
[TBL] [Abstract][Full Text] [Related]
16. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
17. Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women.
Dostal AM; Arikawa A; Espejo L; Bedell S; Kurzer MS; Stendell-Hollis NR
J Hum Nutr Diet; 2017 Apr; 30(2):166-176. PubMed ID: 27600055
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
19. Acute and long-term estradiol kinetics in smoking postmenopausal women.
Bjarnason NH; Jørgensen HL; Christiansen C
Climacteric; 2012 Oct; 15(5):449-54. PubMed ID: 22191426
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of COMT Val158Met polymorphism in Eastern UP population.
Kumar P; Yadav U; Rai V
Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):21-24. PubMed ID: 28968204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
